
Home | Consumers | Health Professionals | Regulatory | Other | Hot Topics | Search
This leaflet is designed to provide you with answers to some common questions about these medicines. It does not contain all the available information and does not take the place of talking with your doctor.
All medicines have risks and benefits. Your doctor has more information about these medicines than is contained in this leaflet. Also, your doctor has had the benefit of taking a full and detailed history from you and is in the best position to make an expert judgement to meet your individual needs.
If you have any concerns about using these medicines, talk to your doctor or pharmacist.
Keep this leaflet with your medicine. You may need to read it again.
HUMALOG insulins are used to reduce high blood sugar (glucose) levels in insulin dependent diabetic patients. Diabetes is a condition in which your pancreas does not produce enough insulin to control your blood sugar level. Extra insulin is therefore needed.
There are two types of diabetes mellitus:
Type 1 diabetes - also called Insulin Dependent Diabetes Mellitus (IDDM).
Patients with type 1 diabetes always need insulin to control their blood sugar
levels.
Type 2 diabetes - also called Non insulin dependent diabetes mellitus (NIDDM). Some patients with type 2 diabetes may also need insulin after initial treatment with diet, exercise and tablets.
HUMALOG insulins are insulin lispro, which works more quickly than soluble human insulin because the insulin molecule has been changed slightly.
HUMALOG MIX25 is 25% insulin lispro and 75% insulin lispro protamine sulfate suspension. This means that the action of HUMALOG MIX25 is prolonged.
HUMALOG MIX50 is 50% insulin lispro and 50% insulin lispro protamine suspension. This means that the action of HUMALOG MIX50 is prolonged.
The abbreviation "rbe" indicates the method of genetic engineering used to manufacture the insulin.
The duration of effect of HUMALOG insulins varies in each individual and also depends on dose, site of injection, blood supply, body temperature and physical activity.
The use of HUMALOG MIX25 and HUMALOG MIX50 has not been studied in children under the age of 18.
This medicine is available only with a doctor's prescription.
Tell your doctor if you have any of the following conditions or if you have ever experienced any of these conditions.
Do not use/inject HUMALOG insulins:
HUMALOG MIX25 or HUMALOG MIX50 should not be given intravenously.
If you are not sure whether you should start using HUMALOG insulins, talk to your doctor or pharmacist.
You must tell your doctor:
Tell your doctor about these things before you use HUMALOG insulins.
Tell your doctor if you are taking any other medicines, including any that you buy without a prescription from your pharmacy, supermarket or health food shop. Some medicines may affect the way your HUMALOG insulin works. These include:
Your doctor or pharmacist has more information on medicines to be careful with or avoid while using HUMALOG insulins.
Tell your doctor about these things before you use HUMALOG insulins.
Follow all directions given to you by your doctor or pharmacist carefully. These may differ from the information contained in this leaflet.
Your doctor may tell you to use HUMALOG with a longer acting human insulin such as HUMULIN NPH. The Consumer Medicine Information leaflet is also available for this product.
There may be a delay in the effect of HUMALOG when it is mixed with HUMULIN NPH, compared to HUMALOG and HUMULIN NPH being injected separately. HUMALOG should not be mixed with any other animal or human insulin preparations.
Your doctor will tell you how much insulin you need to use each day.
Your doctor will tell you the type of HUMALOG that is best suited to you.
Do not change your insulin unless your doctor tells you to. Be very careful if you do change insulin. If you change the type of insulin that you use (for example from human insulin to HUMALOG), you may have to take more or less than before. This may happen with the first injection or it may be a gradual change over several weeks or months.
Inject HUMALOG, HUMALOG MIX25 or HUMALOG MIX50 under the skin. Under no circumstances should HUMALOG MIX25 or HUMALOG MIX50 be given intravenously.
Follow the steps below.
HUMALOG, HUMALOG MIX25 and HUMALOG MIX50 3.0 mL cartridges are only for use with the HumaPen
Do not mix any other insulin in your cartridge. Once the cartridge is empty, do not use it again.
Your doctor will tell you when to use your HUMALOG insulin. You should normally use HUMALOG, HUMALOG MIX25 or HUMALOG MIX50 immediately (or up to 15 minutes) before a meal. When necessary, HUMALOG can be used soon after a meal. When HUMALOG is given after a meal, it must be within 20 minutes of the start of the meal.
Do not stop using your HUMALOG insulin just because you feel better. It is important that you do not stop using your HUMALOG insulin unless your doctor tells you.
Low blood sugar (hypoglycaemia) is the most likely reaction if you have injected more insulin than you need. Symptoms of low blood sugar include drowsiness, confusion, irregular heart beat, headache, sweating and vomiting. If you experience symptoms of low blood sugar, eat some sugary food or drink, such as jelly beans, orange juice or glucose tablets. If you do not feel better after eating/drinking some sugary food or drink, contact your doctor or go to the Emergency Department at your nearest hospital.
Tell all doctors, dentists and pharmacists who are treating you that you are using HUMALOG or HUMALOG MIX25, HUMALOG MIX50.
While you are using HUMALOG insulins, tell your doctor or pharmacist before you start any new medicine.
If you become pregnant while using HUMALOG insulins tell your doctor.
Always carry a supply of your HUMALOG insulin cartridges and your pen with you.
Always carry something to show you have diabetes.
Always carry glucose or sugary foods with you.
Always check for insulin flow before injecting a dose.
Immediately after an injection, remove the needle from the pen. This will ensure sterility and prevent leakage, re-entry of air and potential needle clogs.
Do not stop using your HUMALOG insulin without first checking with your doctor.
Do not give your HUMALOG insulin to anyone else, even if they have the same condition as you. Your doctor has prescribed your HUMALOG insulin specifically for you.
Do not share needles, cartridges or pens.
Do not reuse needles.
Do not inject HUMALOG MIX25 or HUMALOG MOX 50 directly into a vein (intravenously).
You should learn to recognise your own symptoms of hypoglycaemia (low blood sugar). You can then take the appropriate action, when necessary. If you are having problems recognising these symptoms, frequent monitoring of your blood sugar level is recommended.
Tell your doctor or pharmacist as soon as possible if you do not feel well while you are using any of the HUMALOG insulins.
Like other medicines, HUMALOG insulins may cause some unwanted side effects. These are likely to vary from patient to patient. Some side effects may be related to the dose of your insulin so it is important that you never exceed the stated dose. Tell your doctor as soon as possible about any unwanted effects. Your doctor may then decide to adjust the dose of insulin you are using.
All medicines can have side effects. Sometimes they are serious, most of the time they are not. You may need medical treatment if you get some of the side effects.
Ask your doctor or pharmacist to answer any questions you may have.
Tell your doctor if you experience any of the following side effects:
Recognising these mild to moderate hypoglycaemic symptoms early may allow
you to take the necessary steps to avoid more serious hypoglycaemia.
Symptoms of severe hypoglycaemia can include:
If untreated, severe hypoglycaemia may lead to unconsciousness and, in extreme cases, death. If you experience symptoms of low blood sugar (hypoglycaemia), eat some sugary food or drink, such as jelly beans, orange juice or glucose tablets. If you do not feel better after eating/drinking some sugary food or drink, contact your doctor or go to the Emergency Department at your nearest hospital.
Tell your doctor if you notice anything unusual or if you are concerned about any aspect of your health, even if you think the problems are not connected with this medicine and are not referred to in this leaflet.
Keep your cartridges in a fridge between 2°-8°C. Do not freeze any of these HUMALOG insulins.
You may keep the cartridges below 30°C for up to 28 days while you are using them. Do not put your cartridges near heat or in the sun. When the cartridge has been inserted into the pen, the cartridge pen combination should not be put in the fridge.
Do not use a cartridge after the expiry date (month, year) stamped on the label.
All medicines should be kept where young children cannot reach them.
If your doctor tells you to stop using HUMALOG insulins or you find your cartridges have passed their expiry date, please return any leftover cartridges to your pharmacist.
Empty cartridges and needles should be disposed of in a sharps container or similar puncture proof container composed of hard plastic or glass. Ask your doctor, nurse or pharmacist where you can dispose of the container once it is full.
HUMALOG is available in 3.0 mL cartridges. The carton has a maroon band containing a diamond marked 100. The label has a maroon band and a diamond marked 100.
HUMALOG is a clear colourless solution.
HUMALOG MIX25 is available in
3.0 mL cartridges. The carton has a yellow band containing a diamond marked 25.
The label has a maroon and yellow band and a diamond marked 25.
The suspension in HUMALOG MIX25 cartridges is white and cloudy or milky.
HUMALOG MIX50 is available in
3.0 mL cartridges. The carton has a red band containing a diamond marked 50. The
label has a red band and a diamond marked 50.
The suspension in HUMALOG MIX50 cartridges is white and cloudy or milky.
All cartridges in the HUMALOG range contain 100 units of insulin lispro per mL.
HUMALOG also contains meta-Cresol, glycerol, sodium phosphate dibasic, zinc oxide and water for injection.
HUMALOG MIX25 and HUMALOG MIX50 also contains meta-Cresol, phenol, glycerol, sodium phosphate dibasic, protamine sulfate, zinc oxide and water for injection.
Supplied in Australia by:
Eli Lilly Australia Pty. Limited
112 Wharf Road
WEST RYDE NSW 2114
Supplied in New Zealand by:
Eli Lilly and Company (NZ) Ltd
Level 3, Axon House
414-422 Khyber Pass Road
P O Box 109 197
Newmarket AUCKLAND
New Zealand
Australian Registration Numbers:
HUMALOG Cartridges - AUST R 53466
HUMALOG MIX25 Cartridges - AUST R 69163
HUMALOG MIX50 Cartridges - AUST R 69166
You can get more information about diabetes and insulin from:
This leaflet was revised in January 2006